Benign prostatic hyperplasia: dihydrotestosterone and 5 alpha-reductase inhibition therapy.
Imperato-McGinley
J
J
Division of Endocrinology, New York Hospital-Cornell University Medical Center, N.Y. 10021.
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000235:genetics; D058891:5-alpha Reductase Inhibitors; D000818:Animals; D002889:Chromosomes, Human, Pair 2; D002895:Chromosomes, Human, Pair 5; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
D058891:5-alpha Reductase Inhibitors; D018120:Finasteride; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase